Free Trial

Alzamend Neuro (ALZN) SEC Filings & 10K Form

Alzamend Neuro logo
$1.11 -0.14 (-11.20%)
(As of 12/20/2024 05:51 PM ET)

Recent Alzamend Neuro SEC Filings

DateFilerForm TypeView
12/12/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
3:30 PM
Alzamend Neuro (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
3:30 PM
Alzamend Neuro (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
5:01 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
4:20 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
3:30 PM
Alzamend Neuro (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
07/30/2024
5:00 AM
Alzamend Neuro (Filer)
Form NT 10-K
07/12/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
7:52 AM
Alzamend Neuro (Filer)
Form 424B3
07/09/2024
11:15 PM
Alzamend Neuro (Filer)
Form EFFECT
07/08/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
3:31 PM
Alzamend Neuro (Filer)
Form S-1/A
06/26/2024
3:46 PM
Alzamend Neuro (Filer)
Form S-1/A
06/11/2024
3:30 PM
Alzamend Neuro (Filer)
Form DEFA14A
06/03/2024
3:30 PM
Alzamend Neuro (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/22/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
3:30 PM
Alzamend Neuro (Issuer)
McGrath Lynne Fahey (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
05/10/2024
4:06 PM
Alzamend Neuro (Filer)
Form PRE 14A
05/10/2024
5:30 AM
Alzamend Neuro (Filer)
Form 424B5
05/09/2024
3:20 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
3:31 PM
Alzamend Neuro (Filer)
Form DEFA14A
04/23/2024
7:00 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:00 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
3:30 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:30 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:27 PM
Alzamend Neuro (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/22/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
3:30 PM
Alzamend Neuro (Filer)
Form NT 10-Q
03/13/2024
3:30 PM
Alzamend Neuro (Filer)
Form PRE 14A
03/07/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
3:38 PM
Alzamend Neuro (Subject)
AULT MILTON C III (Filed by)
Form SC 13D/A
02/02/2024
3:30 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:30 PM
Alzamend Neuro (Filer)
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
4:20 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
4:21 PM
Alzamend Neuro (Subject)
AULT MILTON C III (Filed by)
Form SC 13D/A
01/09/2024
3:30 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

12/27/2023
3:30 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ALZN) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners